Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
BRE12-158: A Postneoadjuvant, Randomized Phase II Trial of Personalized Therapy Versus Treatment of Physician's Choice for Patients With Residual Triple-Negative Breast CancerJ. Clin. Oncol 2021 Dec 15;[EPub Ahead of Print], BP Schneider, G Jiang, TJ Ballinger, F Shen, C Chitambar, R Nanda, C Falkson, FC Lynce, C Gallagher, C Isaacs, M Blaya, E Paplomata, R Walling, K Daily, R Mahtani, MA Thompson, R Graham, ME Cooper, DC Pavlick, LA Albacker, J Gregg, JP Solzak, YH Chen, CL Bales, E Cantor, BA Hancock, N Kassem, P Helft, B O'Neil, AMV Storniolo, S Badve, KD Miller, M Radovich
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.